Nodep 20 mg (Capsule)
Unit Price: ৳ 3.00 (5 x 10: ৳ 150.00)
Strip Price: ৳ 30.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Fluoxetine hydrochloride |
| Company | General pharmaceuticals ltd |
Title and Categories
- Nodep medicine
- Phenothiazine related drugs
- Antidepressant
- Medication for depressive illness
- Treatment for bulimia nervosa
- Therapeutic drug for obsessive compulsive disorder
Dosage and Administration
- Initial recommended dose of 20 mg/day
- Maximum recommended dose of 80 mg/day
- Maintenance dosage of 60 mg daily for bulimia nervosa
- Lower dosage for patients with renal and/or hepatic impairment
- Lower or less frequent dosage for elderly or patients with concurrent diseases
- Not recommended for use in children
Interaction
- Serious fatal reactions reported with MAO inhibitors
- Greater than two-fold increase in stable plasma levels of other antidepressants
- Reports of increased or decreased lithium levels when used concomitantly with Nodep
- Elevation of blood levels of certain antipsychotics observed
- Elevated plasma anticonvulsant concentrations and clinical anticonvulsant toxicity observed in some patients
Contraindications
- Contraindicated in patients known to be hypersensitive to it
- Not to be used in combination with MAOI or within 14 days of discontinuing therapy with MAOI
- At least 5 weeks should be allowed after stopping Fluoxetine and before starting MAOI
Side Effects
- Gastrointestinal: Nausea, vomiting, dyspepsia, dry mouth, diarrhea
- Neurological: Anxiety, nervousness, insomnia/drowsiness, fatigue
- Excessive sweating, pruritus, skin rashes associated with liver, kidney and lung involvement
Pregnancy & Lactation
- Use in pregnancy only if clearly needed
- Caution should be exercised when administered to nursing women
Precautions & Warnings
- Use with caution and in reduced doses in patients with impaired hepatic or renal function
- Caution in patients with epilepsy or a history of such disorders
- Caution warranted in diabetic subjects
- Careful supervision for depressed patients with suicidal tendencies
- Not usually suitable for the depressive component of bipolar (manic depressive) illness
Pharmacology
- Selectively inhibits the reuptake of serotonin at the presynaptic neuronal membrane
- Causes increased synaptic concentration of serotonin in the CNS
- No effect on the reuptake of norepinephrine and dopamine
- Does not exhibit anticholinergic, antihistaminic or α1 adrenergic blocking activity at usual therapeutic doses
Storage Conditions
- Protect from light and moisture
- Store below 30°C
- Keep in a cool and dry place
- Keep out of the reach of children